BiotechTube
Home/Pipeline/Pipeline of Complex Generics

Pipeline of Complex Generics

Various

Various (Development to Approved)Active

Key Facts

Indication
Various
Phase
Various (Development to Approved)
Status
Active
Company
Solaris Pharma Corporation

About Solaris Pharma Corporation

Solaris Pharma Corporation, founded in 2018, is a privately held, revenue-generating company specializing in complex generic and specialty pharmaceuticals. Its strategy centers on developing difficult-to-manufacture products in dosage forms like topicals, sterile injectables, and tablets, which face high development hurdles but offer attractive market opportunities with limited competition. Led by CEO Shalin Jani, the company has a validated development process, multiple product approvals, and a commercial track record, positioning it as a dependable supplier in a niche segment of the pharmaceutical industry.

View full company profile

Therapeutic Areas

DermatologyMulti-therapeutic

Other Various Drugs

DrugCompanyPhase
New Generic ApprovalsChina SXT PharmaceuticalsApplication Submitted / BE Stage
New Dosage Form DevelopmentUniverse PharmaceuticalsDevelopment
New TCM Formula RegistrationUniverse PharmaceuticalsDevelopment
CBD/THC Oil FormulationAvecho BiotechnologyPreclinical
Bag APIsChemWerthApproved
Oral APIsChemWerthApproved
Companion Diagnostics DevelopmentKiffik BiomedicalPre-clinical
Portfolio of Complex Generics & 505(b)(2) ProductsAlvogenApproved/Commercial
Portfolio of 40+ productsPraxgen PharmaceuticalsDevelopment
Drug Repositioning ServiceBiovistaService
Custom Control DevelopmentAnchor MolecularDevelopment/Commercial
Portfolio from Steriscience PartnershipArmas PharmaceuticalsANDA Development/Filing